Optimization of the dipeptide motifs in the PSMA ligands linker structure: synthesis and in vitro evaluation

An improved series of ligands targeting prostatic specific membrane antigen has been reported. Varying compounds and their biological parameters were due to changes in the linker structure. Highly selective compounds with nanomolar IC 50 values were obtained. As an example, a conjugate with Sulfo-Cy...

Full description

Saved in:
Bibliographic Details
Published inMedicinal chemistry research Vol. 32; no. 1; pp. 32 - 37
Main Authors Uspenskaya, Anastasiia A., Nimenko, Ekaterina A., Shafikov, Radik R., Zyk, Nikolay Y., Evteev, Sergei A., Dashkova, Natalia S., Ivanenkov, Yan A., Majouga, Alexander G., Skvortsov, Dmitry A., Garanina, Anastasiia S., Beloglazkina, Elena K., Machulkin, Aleksei E.
Format Journal Article
LanguageEnglish
Published New York Springer US 01.01.2023
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract An improved series of ligands targeting prostatic specific membrane antigen has been reported. Varying compounds and their biological parameters were due to changes in the linker structure. Highly selective compounds with nanomolar IC 50 values were obtained. As an example, a conjugate with Sulfo-Cy5 and MMAE was obtained and pre-studied. Graphical Abstract
AbstractList An improved series of ligands targeting prostatic specific membrane antigen has been reported. Varying compounds and their biological parameters were due to changes in the linker structure. Highly selective compounds with nanomolar IC 50 values were obtained. As an example, a conjugate with Sulfo-Cy5 and MMAE was obtained and pre-studied. Graphical Abstract
An improved series of ligands targeting prostatic specific membrane antigen has been reported. Varying compounds and their biological parameters were due to changes in the linker structure. Highly selective compounds with nanomolar IC50 values were obtained. As an example, a conjugate with Sulfo-Cy5 and MMAE was obtained and pre-studied.
Author Machulkin, Aleksei E.
Uspenskaya, Anastasiia A.
Skvortsov, Dmitry A.
Zyk, Nikolay Y.
Beloglazkina, Elena K.
Evteev, Sergei A.
Majouga, Alexander G.
Nimenko, Ekaterina A.
Ivanenkov, Yan A.
Garanina, Anastasiia S.
Shafikov, Radik R.
Dashkova, Natalia S.
Author_xml – sequence: 1
  givenname: Anastasiia A.
  orcidid: 0000-0002-2451-8336
  surname: Uspenskaya
  fullname: Uspenskaya, Anastasiia A.
  email: uspenskaya.n@gmail.com
  organization: Chemistry Department, Lomonosov Moscow State University
– sequence: 2
  givenname: Ekaterina A.
  surname: Nimenko
  fullname: Nimenko, Ekaterina A.
  organization: Chemistry Department, Lomonosov Moscow State University
– sequence: 3
  givenname: Radik R.
  surname: Shafikov
  fullname: Shafikov, Radik R.
  organization: Chemistry Department, Lomonosov Moscow State University, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry Russian Academy of Sciences
– sequence: 4
  givenname: Nikolay Y.
  surname: Zyk
  fullname: Zyk, Nikolay Y.
  organization: Chemistry Department, Lomonosov Moscow State University
– sequence: 5
  givenname: Sergei A.
  surname: Evteev
  fullname: Evteev, Sergei A.
  organization: The Federal State Unitary Enterprise Dukhov Automatics Research Institute
– sequence: 6
  givenname: Natalia S.
  surname: Dashkova
  fullname: Dashkova, Natalia S.
  organization: Chemistry Department, Lomonosov Moscow State University
– sequence: 7
  givenname: Yan A.
  surname: Ivanenkov
  fullname: Ivanenkov, Yan A.
  organization: Chemistry Department, Lomonosov Moscow State University, The Federal State Unitary Enterprise Dukhov Automatics Research Institute, National University of Science and Technology «MISiS», Institute of Biochemistry and Genetics Ufa Science Centre Russian Academy of Sciences (IBG RAS)
– sequence: 8
  givenname: Alexander G.
  surname: Majouga
  fullname: Majouga, Alexander G.
  organization: Chemistry Department, Lomonosov Moscow State University, National University of Science and Technology «MISiS», Dmitry Mendeleev University of Chemical Technology of Russia
– sequence: 9
  givenname: Dmitry A.
  surname: Skvortsov
  fullname: Skvortsov, Dmitry A.
  organization: Chemistry Department, Lomonosov Moscow State University
– sequence: 10
  givenname: Anastasiia S.
  surname: Garanina
  fullname: Garanina, Anastasiia S.
  organization: National University of Science and Technology «MISiS»
– sequence: 11
  givenname: Elena K.
  surname: Beloglazkina
  fullname: Beloglazkina, Elena K.
  organization: Chemistry Department, Lomonosov Moscow State University
– sequence: 12
  givenname: Aleksei E.
  surname: Machulkin
  fullname: Machulkin, Aleksei E.
  organization: Chemistry Department, Lomonosov Moscow State University
BookMark eNp9kEtLxDAUhYMoOD7-gKuA6-rNozZ1Nwy-QBlBXYe0TTRjJx2TdAb99cZWEFzM6h4u57uPc4B2Xec0QicEzghAcR4AgPMMKM2AAdBss4MmJM95JgiF3aQhaZpTto8OQlgAsAJ4PkHtfBXt0n6paDuHO4Pjm8aNXenUbjRedtGagK0b-o9PD1Pc2lflmpCqe9ceh-j7OvZeX-Lw6ZIr2ICT4YdZ2-g7rNeq7Yf5R2jPqDbo4996iF6ur55nt9n9_OZuNr3PakbKmImCCKZVXrKyUiSvK2EaXWtem6riuRGcqoJUxlAhcsbTv2XylZUgqmrKC8PZITod565899HrEOWi671LKyUtLgglIGiZXHR01b4LwWsjV94ulf-UBORPqnJMVaZU5ZCq3CRI_INqG4fnole23Y6yEQ1pj3vV_u-qLdQ3pR2Qcw
CitedBy_id crossref_primary_10_71267_mencom_7583
crossref_primary_10_1016_j_bmcl_2024_130025
crossref_primary_10_1021_acsptsci_4c00070
crossref_primary_10_1016_j_jconrel_2024_09_040
crossref_primary_10_1134_S1070428024080013
crossref_primary_10_31857_S0514749224020058
crossref_primary_10_3390_ijms241411327
Cites_doi 10.1021/acs.jmedchem.1c01157
10.2174/0929867328666210804092200
10.1016/j.bmc.2018.11.022
10.1021/acs.jmedchem.0c01935
10.7150/thno.18719
10.1158/1078-0432.CCR-18-0803
10.1016/j.bmcl.2019.06.035
10.14309/ctg.0000000000000041
10.1093/annonc/mdx370
10.2967/jnumed.116.178533
10.1039/c0md00273a
10.1016/j.bioorg.2019.103154
10.3390/molecules25245784
10.1038/s41598-021-86551-1
10.3322/caac.21660
10.1158/1078-0432.CCR-14-0891
10.2967/jnumed.115.158550
10.1056/nejmoa2107322
10.1021/cr100048w
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022
The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022.
Copyright_xml – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022
– notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022.
DBID AAYXX
CITATION
8FD
FR3
M7Z
P64
DOI 10.1007/s00044-022-03002-w
DatabaseName CrossRef
Technology Research Database
Engineering Research Database
Biochemistry Abstracts 1
Biotechnology and BioEngineering Abstracts
DatabaseTitle CrossRef
Biochemistry Abstracts 1
Engineering Research Database
Technology Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitleList
Biochemistry Abstracts 1
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1554-8120
EndPage 37
ExternalDocumentID 10_1007_s00044_022_03002_w
GroupedDBID ---
-56
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
1N0
203
29M
29~
2J2
2JN
2JY
2KG
2LR
2VQ
2~H
30V
4.4
406
408
409
40D
40E
5GY
5VS
67N
67Z
6NX
78A
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACSNA
ACZOJ
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFFNX
AFGCZ
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BAPOH
BDATZ
BGNMA
BSONS
CAG
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBLON
EBS
EIOEI
EJD
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HLICF
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
IHE
IJ-
IKXTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
LAS
LLZTM
M4Y
MA-
N2Q
NB0
NPVJJ
NQJWS
NU0
O9-
O93
O9I
O9J
OAM
P2P
PF0
PT4
QOR
QOS
R89
R9I
RIG
ROL
RPX
RSV
S16
S1Z
S27
S3A
S3B
SAP
SBL
SDH
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZN
T13
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WK8
YLTOR
Z45
Z7U
Z7V
Z87
ZMTXR
ZOVNA
~A9
~KM
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
8FD
ABRTQ
FR3
M7Z
P64
ID FETCH-LOGICAL-c319t-87183ea5939ba15cb8fdece4cfbb45f842a71bff28853403099ba9b81abd96f43
IEDL.DBID U2A
ISSN 1054-2523
IngestDate Fri Jul 25 11:03:26 EDT 2025
Tue Jul 01 01:53:35 EDT 2025
Thu Apr 24 23:04:36 EDT 2025
Fri Feb 21 02:46:34 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Monomethyl auristatin E
Drug delivery
Sulfo-Cy5 label
Prostate cancer
Prostate-specific membrane antigen
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c319t-87183ea5939ba15cb8fdece4cfbb45f842a71bff28853403099ba9b81abd96f43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ORCID 0000-0002-2451-8336
PQID 2761210829
PQPubID 2043723
PageCount 6
ParticipantIDs proquest_journals_2761210829
crossref_primary_10_1007_s00044_022_03002_w
crossref_citationtrail_10_1007_s00044_022_03002_w
springer_journals_10_1007_s00044_022_03002_w
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20230100
2023-01-00
20230101
PublicationDateYYYYMMDD 2023-01-01
PublicationDate_xml – month: 1
  year: 2023
  text: 20230100
PublicationDecade 2020
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: Heidelberg
PublicationTitle Medicinal chemistry research
PublicationTitleAbbrev Med Chem Res
PublicationYear 2023
Publisher Springer US
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer Nature B.V
References El-Faham, Albericio (CR15) 2011; 111
Schmidt (CR17) 2017
Sung, Ferlay, Siegel, Laversanne, Soerjomataram, Jemal (CR1) 2021; 71
Machulkin, Skvortsov, Ivanenkov, Ber, Kavalchuk, Aladinskaya (CR18) 2019; 29
Kularatne, Thomas, Myers, Gagare, Kanduluru, Crian (CR9) 2019; 25
Barinka, Novakova, Hin, Bím, Ferrari, Duvall (CR4) 2019; 27
Boinapally, Ahn, Cheng, Brummet, Nam, Gabrielson (CR10) 2021; 11
Jiao, Li, Yang, Han, Wu, Shi (CR2) 2019; 10
Sengupta, Krishnan, Pandit, Dudhe, Sharma, Chelvam (CR11) 2019; 91
Sartor, Bono, Chi, Fizazi, Herrmann, Rahbar (CR3) 2021; 385
Chi, Protheroe, Rodriguez Antolin, Facchini, Suttmann, Matsubara (CR5) 2017; 28
Petrov, Machulkin, Uspenskaya, Zyk, Nimenko, Garanina (CR19) 2020; 25
Neuman, Eifler, Castanares, Chowdhury, Chen, Mease (CR8) 2015; 21
Ahmadzadehfar, Azgomi, Hauser, Wei, Yordanova, Gaertner (CR7) 2017; 58
Wang, Shirke, Walker, Sun, Ramamurthy, Wang (CR20) 2021; 13
Weineisen, Schottelius, Simecek, Baum, Yildiz, Beykan (CR12) 2015; 56
Machulkin, Shafikov, Uspenskaya, Petrov, Ber, Skvortsov (CR13) 2021; 64
Uspenskaya, Nimenko, Machulkin, Beloglazkina, Majouga (CR14) 2021; 28
Choy, Ling, Geruntho, Beyer, Latoche, Langton-Webster (CR6) 2017; 7
Machulkin, Uspenskaya, Zyk, Nimenko, Ber, Petrov (CR21) 2021; 64
East, Carter, Kennedy, Schulte, Toews, Lynch (CR16) 2011; 2
A El-Faham (3002_CR15) 2011; 111
K Chi (3002_CR5) 2017; 28
AE Machulkin (3002_CR18) 2019; 29
CJ Choy (3002_CR6) 2017; 7
SA Kularatne (3002_CR9) 2019; 25
JE East (3002_CR16) 2011; 2
H Ahmadzadehfar (3002_CR7) 2017; 58
S Sengupta (3002_CR11) 2019; 91
S Boinapally (3002_CR10) 2021; 11
O Sartor (3002_CR3) 2021; 385
C Barinka (3002_CR4) 2019; 27
AE Machulkin (3002_CR21) 2021; 64
D Jiao (3002_CR2) 2019; 10
X Wang (3002_CR20) 2021; 13
BP Neuman (3002_CR8) 2015; 21
AE Machulkin (3002_CR13) 2021; 64
H Sung (3002_CR1) 2021; 71
AA Uspenskaya (3002_CR14) 2021; 28
A Schmidt (3002_CR17) 2017
SA Petrov (3002_CR19) 2020; 25
M Weineisen (3002_CR12) 2015; 56
References_xml – volume: 64
  start-page: 17123
  year: 2021
  end-page: 45
  ident: CR21
  article-title: Synthesis, characterization, and preclinical evaluation of a small-molecule prostate-specific membrane antigen-targeted monomethyl auristatin E conjugate
  publication-title: J Med Chem
  doi: 10.1021/acs.jmedchem.1c01157
– volume: 28
  start-page: 1
  year: 2021
  end-page: 31
  ident: CR14
  article-title: The importance of linkers in the structure of PSMA ligands
  publication-title: Curr Med Chem
  doi: 10.2174/0929867328666210804092200
– volume: 27
  start-page: 255
  year: 2019
  end-page: 64
  ident: CR4
  article-title: Structural and computational basis for potent inhibition of glutamate carboxypeptidase II by carbamate-based inhibitors
  publication-title: Bioorg Med Chem
  doi: 10.1016/j.bmc.2018.11.022
– volume: 64
  start-page: 4532
  year: 2021
  end-page: 52
  ident: CR13
  article-title: Synthesis and biological evaluation of PSMA ligands with aromatic residues and fluorescent conjugates based on them
  publication-title: J Med Chem
  doi: 10.1021/acs.jmedchem.0c01935
– year: 2017
  ident: CR17
  publication-title: Structural modifications of PSMA ligands to optimize their pharmacokinetics
– volume: 7
  start-page: 1928
  year: 2017
  end-page: 39
  ident: CR6
  article-title: 177Lu-labeled phosphoramidate-based PSMA inhibitors: the effect of an albumin binder on biodistribution and therapeutic efficacy in prostate tumor-bearing mice
  publication-title: Theranostics
  doi: 10.7150/thno.18719
– volume: 25
  start-page: 177
  year: 2019
  end-page: 87
  ident: CR9
  article-title: Evaluation of novel prostate-specific membrane antigen-targeted near-infrared imaging agent for fluorescence-guided surgery of prostate cancer
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-18-0803
– volume: 29
  start-page: 2229
  year: 2019
  end-page: 35
  ident: CR18
  article-title: Synthesis and biological evaluation of PSMA-targeting paclitaxel conjugates
  publication-title: Bioorg Med Chem Lett
  doi: 10.1016/j.bmcl.2019.06.035
– volume: 10
  start-page: 1
  year: 2019
  end-page: 7
  ident: CR2
  article-title: Expression of prostate-specific membrane antigen in tumor-associated vasculature predicts poor prognosis in hepatocellular carcinoma
  publication-title: Clin Transl Gastroenterol
  doi: 10.14309/ctg.0000000000000041
– volume: 28
  start-page: v269.
  year: 2017
  ident: CR5
  article-title: Benefits of abiraterone acetate plus prednisone (AA+P) when added to androgen deprivation therapy (ADT) in LATITUDE on patient (Pt) reported outcomes (PRO)
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdx370
– volume: 58
  start-page: 438
  year: 2017
  end-page: 44
  ident: CR7
  article-title: 68Ga-PSMA-11 PET as a gatekeeper for the treatment of metastatic prostate cancer with 223Ra: proof of concept
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.116.178533
– volume: 2
  start-page: 325
  year: 2011
  end-page: 30
  ident: CR16
  article-title: Development of a phosphatase-resistant, l-tyrosine derived LPA1/LPA3 dual antagonist
  publication-title: Medchemcomm
  doi: 10.1039/c0md00273a
– volume: 91
  start-page: 103154.
  year: 2019
  ident: CR11
  article-title: Tyrosine-based asymmetric urea ligand for prostate carcinoma: tuning biological efficacy through in silico studies
  publication-title: Bioorg Chem
  doi: 10.1016/j.bioorg.2019.103154
– volume: 25
  start-page: 5784
  year: 2020
  ident: CR19
  article-title: Polypeptide-based molecular platform and its docetaxel/sulfo-Cy5-containing conjugate for targeted delivery to prostate specific membrane antigen
  publication-title: Molecules
  doi: 10.3390/molecules25245784
– volume: 11
  start-page: 1
  year: 2021
  end-page: 10
  ident: CR10
  article-title: A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile
  publication-title: Sci Rep
  doi: 10.1038/s41598-021-86551-1
– volume: 71
  start-page: 209
  year: 2021
  end-page: 49
  ident: CR1
  article-title: Global Cancer Statistics 2020 Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21660
– volume: 21
  start-page: 771
  year: 2015
  end-page: 80
  ident: CR8
  article-title: Real-time, near-infrared fluorescence imaging with an optimized dye/light source/camera combination for surgical guidance of prostate cancer
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-14-0891
– volume: 56
  start-page: 1169
  year: 2015
  end-page: 76
  ident: CR12
  article-title: Ga- and Lu-labeled PSMA I & T: optimization of a PSMA targeted theranostic concept and first proof of concept human studies
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.115.158550
– volume: 385
  start-page: 1091
  year: 2021
  end-page: 103
  ident: CR3
  article-title: Lutetium-177–PSMA-617 for metastatic castration-resistant prostate cancer
  publication-title: N. Engl J Med
  doi: 10.1056/nejmoa2107322
– volume: 13
  start-page: 1
  year: 2021
  end-page: 21
  ident: CR20
  article-title: Small molecule-based prodrug targeting prostate specific membrane antigen for the treatment of prostate cancer
  publication-title: Cancers (Basel)
– volume: 111
  start-page: 6557
  year: 2011
  end-page: 602
  ident: CR15
  article-title: Peptide coupling reagents, more than a letter soup
  publication-title: Chem Rev
  doi: 10.1021/cr100048w
– volume: 25
  start-page: 177
  year: 2019
  ident: 3002_CR9
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-18-0803
– volume: 25
  start-page: 5784
  year: 2020
  ident: 3002_CR19
  publication-title: Molecules
  doi: 10.3390/molecules25245784
– volume: 10
  start-page: 1
  year: 2019
  ident: 3002_CR2
  publication-title: Clin Transl Gastroenterol
  doi: 10.14309/ctg.0000000000000041
– volume: 21
  start-page: 771
  year: 2015
  ident: 3002_CR8
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-14-0891
– volume: 71
  start-page: 209
  year: 2021
  ident: 3002_CR1
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21660
– volume: 58
  start-page: 438
  year: 2017
  ident: 3002_CR7
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.116.178533
– volume: 56
  start-page: 1169
  year: 2015
  ident: 3002_CR12
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.115.158550
– volume: 11
  start-page: 1
  year: 2021
  ident: 3002_CR10
  publication-title: Sci Rep
  doi: 10.1038/s41598-021-86551-1
– volume-title: Structural modifications of PSMA ligands to optimize their pharmacokinetics
  year: 2017
  ident: 3002_CR17
– volume: 111
  start-page: 6557
  year: 2011
  ident: 3002_CR15
  publication-title: Chem Rev
  doi: 10.1021/cr100048w
– volume: 27
  start-page: 255
  year: 2019
  ident: 3002_CR4
  publication-title: Bioorg Med Chem
  doi: 10.1016/j.bmc.2018.11.022
– volume: 28
  start-page: 1
  year: 2021
  ident: 3002_CR14
  publication-title: Curr Med Chem
  doi: 10.2174/0929867328666210804092200
– volume: 91
  start-page: 103154.
  year: 2019
  ident: 3002_CR11
  publication-title: Bioorg Chem
  doi: 10.1016/j.bioorg.2019.103154
– volume: 2
  start-page: 325
  year: 2011
  ident: 3002_CR16
  publication-title: Medchemcomm
  doi: 10.1039/c0md00273a
– volume: 13
  start-page: 1
  year: 2021
  ident: 3002_CR20
  publication-title: Cancers (Basel)
– volume: 28
  start-page: v269.
  year: 2017
  ident: 3002_CR5
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdx370
– volume: 29
  start-page: 2229
  year: 2019
  ident: 3002_CR18
  publication-title: Bioorg Med Chem Lett
  doi: 10.1016/j.bmcl.2019.06.035
– volume: 7
  start-page: 1928
  year: 2017
  ident: 3002_CR6
  publication-title: Theranostics
  doi: 10.7150/thno.18719
– volume: 64
  start-page: 4532
  year: 2021
  ident: 3002_CR13
  publication-title: J Med Chem
  doi: 10.1021/acs.jmedchem.0c01935
– volume: 64
  start-page: 17123
  year: 2021
  ident: 3002_CR21
  publication-title: J Med Chem
  doi: 10.1021/acs.jmedchem.1c01157
– volume: 385
  start-page: 1091
  year: 2021
  ident: 3002_CR3
  publication-title: N. Engl J Med
  doi: 10.1056/nejmoa2107322
SSID ssj0037045
Score 2.3249176
Snippet An improved series of ligands targeting prostatic specific membrane antigen has been reported. Varying compounds and their biological parameters were due to...
SourceID proquest
crossref
springer
SourceType Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 32
SubjectTerms Antigens
Biochemistry
Biomedical and Life Sciences
Biomedicine
Bioorganic Chemistry
Brief Report
Inorganic Chemistry
Ligands
Medicinal Chemistry
Optimization
Pharmacology/Toxicology
Title Optimization of the dipeptide motifs in the PSMA ligands linker structure: synthesis and in vitro evaluation
URI https://link.springer.com/article/10.1007/s00044-022-03002-w
https://www.proquest.com/docview/2761210829
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NT8IwFG8ULl6MnxFF0oPhIktY17HN2zAg0YgkQoKnpd1aswQHYSjhv_e121g0auJpyfbaQ1_f1957v4fQFTOZFA53jDYnzKDUcw1uhsSgMgJ1KYWKQlS1xbAzmND7qT3Nm8LSotq9SElqTb1tdtPJR0NVn8PFBDle76KqDbG7KuSaEL_Qv5bT1qOJwXGgBoE4K2-V-XmPr-ao9DG_pUW1tekfoP3cTcR-xtdDtCOSI9QcZTjTmxYel21TaQs38ahEoN4co9kTKIK3vMMSzyUGLw9H8UJVsEQCq_o7meI40e9Hz48-nsWvqucXq4MRS5yhyr4vxQ1ONwlQpXGKgUCt-YhXyzkuUcJP0KTfG98OjHysghGCvK1A_4EYC2Z7lseZaYfclZEIBQ0l59SWLiXMMbmUxAVTTlUKBug87pqMR15HUusUVZJ5Is4Q9tpAKghxmZA0ci3GGEQcVkd2ojAEWa8hszjdIMwxx9Xoi1mwRUvWHAmAI4HmSLCuoevtmkWGuPEndb1gWpBLXxoQR-OiucSroVbByPLz77ud_4_8Au2p6fPZH5k6qgBvxCX4KCveQFW_3-0O1fPu5aHX0Ff0EzfP4kw
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fT9swED4x9sBe0DaY1gHjHgYvNFLjuI0ziYdqA5XxqxKtxFtmJzaK1KWoKVT9f_aH7uwkjZi2SXvgNTlbkb-78zl39xngk_Sl0aEKvY5i0uM8Ep7yE-Zxk5K7NNqeQmy1xVVvMObfbru3a_Cz7oVx1e51StJ56lWzm0s-erb6nBST7HhRlVKe6-WCDmrF8dlXQvWAsdOT0ZeBV90l4CWkZHMyetJdLbtRECnpdxMlTKoTzROjFO8awZkMfWUME7R_cZt3ILlICV-qNOoZHtC8L-AlBR_C2s6Y9Wt_H4QddxUyBSrcY3Suq1pz_vzNT7e_Jqb9LQ3rdrfT17BZhaXYL_XoDazp_C0cDkte62UbR02bVtHGQxw2jNfLLZhck-P5UXV04tQgRZWYZve2YibVaOv9TIFZ7p4Pby77OMnubI8xWiD0DEsW24eZ_ozFMiepIiuQBOyYx2w-m2LDSr4N42dZ-newnk9z_R4w6pCoZkxIbXgqAiklnXCCnumlSUK-pQV-vbpxUnGc26s2JvGKndkhEhMisUMkXrTgaDXmvmT4-Kf0bg1aXFl7EbPQ8bAJFrWgXQPZvP77bB_-T3wfNgajy4v44uzqfAdeMYq3yr9Bu7BOOOk9io_m6qNTT4Tvz20PvwBsHB1c
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dT9swED8xkKa9ID42rYOxexi8rBGN4zYJEg8VrILxVWlU4i2zE3uKVNKqKVT9r_gTd3aSRiCGxAOvydmK_Ls7n3N3PwN8F67Qype-05JMOJyHgSPdmDlcJ-QutTKnEFNtcdk5GfBfN-2bJXioemFstXuVkix6GgxLUzbdHyd6f9H4ZhORjqlEJyUlm56VZZVnaj6jQ1t-eHpMCO8y1vt5fXTilPcKODEp3JQcAOmxEu3QC6Vw27EMdKJixWMtJW_rgDPhu1JrFtBexk0OguRCGbhCJmFHc4_mfQcr3HQfkwUNWLfy_Z7fstciU9DCHUZnvLJN5_lvfrwV1vHtk5Ss3el6a7BahqjYLXRqHZZUtgF7_YLjet7E67plK2_iHvZr9uv5JgyvyAndlt2dONJIESYm6dhUzyQKTe2fzjHN7PP-74suDtO_pt8YDShqggWj7d1EHWA-z0gqT3MkATPmPp1ORlgzlH-EwZss_SdYzkaZ-gwYtkhUMRYIpXkSeEIIOu14Hd1J4pj8TAPcanWjuOQ7N9duDKMFU7NFJCJEIotINGvAj8WYccH28aL0dgVaVFp-HjHfcrIFLGxAswKyfv3_2b68TvwbvO8f96Lz08uzLfjAKPQqfgxtwzLBpL5SqDSVO1Y7Ef68tTn8A-S2IY8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Optimization+of+the+dipeptide+motifs+in+the+PSMA+ligands+linker+structure%3A+synthesis+and+in+vitro+evaluation&rft.jtitle=Medicinal+chemistry+research&rft.au=Uspenskaya%2C+Anastasiia+A&rft.au=Nimenko%2C+Ekaterina+A&rft.au=Shafikov+Radik+R&rft.au=Zyk%2C+Nikolay+Y&rft.date=2023-01-01&rft.pub=Springer+Nature+B.V&rft.issn=1054-2523&rft.eissn=1554-8120&rft.volume=32&rft.issue=1&rft.spage=32&rft.epage=37&rft_id=info:doi/10.1007%2Fs00044-022-03002-w&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1054-2523&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1054-2523&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1054-2523&client=summon